Bpi Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BPI LABS, and what generic alternatives to BPI LABS drugs are available?
BPI LABS has seven approved drugs.
There are three US patents protecting BPI LABS drugs. There is one tentative approval on BPI LABS drugs.
Summary for Bpi Labs
| US Patents: | 3 |
| Tradenames: | 7 |
| Ingredients: | 7 |
| NDAs: | 7 |
Drugs and US Patents for Bpi Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | ABLYSINOL | alcohol | SOLUTION;INTRA-ARTERIAL | 207987-002 | Jun 21, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029-004 | Feb 14, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS | 205029-003 | May 12, 2023 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
